STAT1 and non-small cell lung carcinoma: Collectively, these findings suggest that the STAT1 agonist SB02024 effectively suppresses the proliferation, migration, and invasion of NSCLC cells, partially counteracting the pro-tumorigenic effects induced by BIN1 knockout.